Savara Announces It Will Present New Data From Phase 3 IMPALA-2 Trial Of Molgramostim Inhalation Solution In Patients With Autoimmune Pulmonary Alveolar Proteinosis At European Respiratory Society Congress 2025
Benzinga Newsdesk 1 year ago
BiotechNewsGeneral
Savara's Partner, TrilliumBiO, to Present Data on the Development of a Dried Blood Spot Test to Aid in the Diagnosis of aPAP —Savara Inc. (NASDAQ:SVRA) (the Company), a clinical-stage biopharmaceutical company focused on
Savara's Partner, TrilliumBiO, to Present Data on the Development of a Dried Blood Spot Test to Aid in the Diagnosis of aPAP —
Savara Inc. (NASDAQ:SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of three abstracts for poster presentation at the European Respiratory Society (ERS) Congress 2025, September 27 – October 1, Amsterdam, The Netherlands. The Company will also host an Industry Evening Mini Symposium titled "Advances in Autoimmune Pulmonary Alveolar Proteinosis" at the meeting.
ERS Congress 2025 Posters & Industry Symposium
Savara
Poster Title: Relationship Between Pulmonary Gas Transfer, Respiratory Health-Related Quality of Life (HRQoL), Exercise Capacity, and Surfactant Burden in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Session Title: PS-37 / Interstitial Lung Diseases / Respiratory Critical Care / Alveolar Filling Disorders and Autoimmune Lung Diseases
Date/Time of Poster Discussion Session: Monday, September 29, 2025, 8:00 - 9:30 CEST
Poster Number: PA3027
Location: RAI Amsterdam, Netherlands
Presenter: Francesco Bonella, M.D., Ph.D., Head of the Center for Interstitial and Rare Lung Diseases and Assistant Professor, Ruhrlandklinik University Hospital, Essen, Germany
Poster Title: Efficacy of Inhaled Molgramostim According to Severity of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Session Title: PS-37 / Interstitial Lung Diseases / Respiratory Critical Care / Alveolar Filling Disorders and Autoimmune Lung Diseases
Date/Time of Poster Presentation Session: Monday, September 29, 2025, 8:00 - 9:30 CEST
Poster Number: PA3026
Location: RAI Amsterdam, Netherlands
Presenter: Cormac McCarthy, M.D., Ph.D., FRCPI, Associate Professor of Medicine at the University College Dublin (UCD) and Consultant Respiratory Physician, St. Vincent's University Hospital, Dublin, Ireland
TrilliumBiO
Poster Title: Development of a Dried Serum Assay for the Detection of GM-CSF Antibodies to Aid in the Diagnosis of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Session Title: PS-37 / Interstitial Lung Diseases / Respiratory Critical Care / Alveolar Filling Disorders and Autoimmune Lung Diseases
Date/Time of Poster Presentation Session: Monday, September 29, 2025, 8:00 - 9:30 CEST
Poster Number PA3025
Location: RAI Amsterdam, Netherlands
Presenter: Eagappanath Thiruppathi, Ph.D., Director of Test and Method Development, TrilliumBiO